Mark Polizzotto (Australia)

Kirby Institute, UNSW Sydney Therapeutic and Vaccine Research Program

Presenter of 1 Presentation

 Conference Calendar
Oral Session 3: Clinical Aspects of Cervical Prevention and Treatment Hall C

CLEARANCE OF HSIL AND MODULATION OF IMMUNE RESPONSES TO HPV ONCOGENES WITH LOW DOSE POMALIDOMIDE: A PHASE II STUDY IN INDIVIDUALS WITH PERSISTENT ANAL HSIL (ID 1138)

Session Date
07/22/2020
Session Time
07:45 - 08:35
Room
Hall C
Session Type
Clinical Science Oral Session
Session Name
Oral Session 3: Clinical Aspects of Cervical Prevention and Treatment
Lecture Time
08:21 - 08:33
Presenter
Authors